Some features may not work as expected in this browser. For the full NewsNow experience, please consider updating your browser or trying a different device. Some features may not work as expected.
Please consider updating your browser or device.

Home
Hot Topics
US
Politics
World
Sports
Business
Crypto
Entertainment
Lifestyle
AI
Tech
Science

Novartis
Pharmaceuticals
GSK
Sanofi
Novo Nordisk
Topics

Advertisement

Advertisement

Novartis

Share

Top Latest Popular

Novartis confirms nine tumor reports after Zolgensma gene therapy, with two showing signs of vector DNA integration Medical Daily 13h

Medical Daily 13h

Novartis: 3 Key takeaways for long-term investors The Motley Fool 4d

The Motley Fool 4d

Novartis reports $2.2bn hit from drug trial setbacks, but lifts guidance The Irish Times 16:34 Tue, 27 Oct

The Irish Times 16:34 Tue, 27 Oct

Pharma Global Health

Advertisement

Advertisement

Novartis takes $1.9bn hit from Avidity takeover in Q3 pharmaphorum 13:32 Tue, 27 Oct

pharmaphorum 13:32 Tue, 27 Oct

Novartis presents positive results from two phase 3 trials for relapsing MS PMLiVE 11:43 Wed, 28 Oct

PMLiVE 11:43 Wed, 28 Oct

Multiple Sclerosis Health

Kisqali Os gain came sooner than expected in early breast cancer: oncologist Korea Biomedical Review 3d

Korea Biomedical Review 3d

Kisqali Breast Cancer

Advertisement

Advertisement

Latest

Yesterday

Novartis and Eastern Air Logistics Explore New Drug Supply Chain Paths in China China Money Network 16:06 Sat, 07 Nov

Novartis Confirms Nine Tumor Reports After Zolgensma Gene Therapy, With Two Showing Signs of Vector DNA Integration Medical Daily 15:48 Sat, 07 Nov

Failure of Novartis Lp(a) drug raises questions about cardiovascular strategy STAT 14:54 Sat, 07 Nov

FDA Investigates Cancer Risk Associated With Novartis' Zolgensma Gene Therapy RTT News 12:50 Sat, 07 Nov

Novartis reveals cancer cases possibly linked to gene therapy Zolgensma BioPharma Dive 04:44 Sat, 07 Nov

FDA investigates tumour risk linked to Novartis’ Zolgensma gene therapy The Hindu Business Line 04:01 Sat, 07 Nov

Friday

Gene Therapy Under Scrutiny After Nine Tumor Reports Medpage Today 22:32 Fri, 06 Nov

Pharmalittle: We’re reading about a Novartis gene therapy, faster U.K. drug reviews, and more STAT 14:46 Fri, 06 Nov

Novartis reports cases of tumours in children following treatment with Zolgensma Swiss Info 14:45 Fri, 06 Nov

Thursday

Novartis cites cases of previously unknown tumors possibly tied to its SMA gene therapy STAT 18:56 Thu, 05 Nov

Advertisement

Advertisement

Advertisement

Advertisement

About our Novartis news

Latest news for Novartis, a global healthcare company based in Switzerland specialising in pharmaceuticals, including updates on company and product news.

News Now

Our Sites

News Now Nigeria

News Now România

News Now Italia

News Now Canada

News Now Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Business Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Takeda Takeda
- Teva Teva
- Zoetis Zoetis